Chronic Gastritis: Clinical Trials

8 trials for Chronic Gastritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Unknown 3

Follow Chronic Gastritis: new trials by email Literature Review of Chronic Gastritis trials Research Report on Chronic Gastritis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
DWP14012 X mg, DWP14012 X mg placebo, DWP14012 Y mg - Acute Gastritis, Chronic Gastritis
Phase 3CompletedDaewoong Pharmaceutical Co. LTD.3272020-06-022021-12-21
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
MCT-SR, Mucosta Tab. - Acute Gastritis, Chronic Gastritis
Phase 3CompletedKorea Otsuka Pharmaceutical Co., Ltd.3922019-12-302021-03-11
A Study to Evaluate the Efficacy and Safety of AD-203
AD-203, Mucosta tab. - Acute Gastritis, Chronic Gastritis
Phase 3CompletedAddpharma Inc.4752019-09-232020-12-02
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
MCE, Standard gastroscopy - Gastric Diseases,, Gastric Ulcer,
Phase 3CompletedChanghai Hospital3502014-08-012015-07-21
A Study to Evaluate the Efficacy and Safety of DA-5204
DA-5204, Stillen tab. - Acute Gastritis, Chronic Gastritis
Phase 3UnknownDong-A ST Co., Ltd.4342014-04-012014-11-04
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
DA-6034, Rebamipide 300mg - Acute Gastritis, Chronic Gastritis
Phase 3UnknownDong-A Pharmaceutical Co., Ltd.4922010-10-012013-03-22
Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
Rebamipide - Dyspepsia, Chronic Gastritis
Phase 3CompletedPT Otsuka Indonesia552007-10-012013-05-15
Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
esomeprazole, moxifloxacin, amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 3UnknownTechnische Universität Dresden1322007-01-012007-04-04

Narrower conditions

Dyspepsia (1)  ·  Polyposis, Gastric (1)  ·  Stomach Diseases (1)  ·  Stomach Neoplasms (1)  ·  Stomach Ulcer (1)

Broader conditions

Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Duodenal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peptic Ulcer (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

rebamipide (2)  ·  Amoxicillin (1)  ·  DA 9601 (1)  ·  DA-5204 (1)  ·  Endoscopy (1)  ·  Esomeprazole (1)  ·  Moxifloxacin (1)  ·  recoflavone (1)

Sponsors

Addpharma Inc. (1)  ·  Changhai Hospital (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  Dong-A Pharmaceutical Co., Ltd. (1)  ·  Dong-A ST Co., Ltd. (1)  ·  Korea Otsuka Pharmaceutical Co., Ltd. (1)  ·  PT Otsuka Indonesia (1)  ·  Technische Universität Dresden (1)

Countries

South Korea (5)  ·  China (1)  ·  Germany (1)  ·  Indonesia (1)

Top investigators

Jeong Seop Moon, M.D., Ph.D. (2)  ·  Suck Chei Choi, M.D., Ph.D. (2)  ·  Aziz Rani, MD (1)  ·  Byung Chul Yoon, M.D., Ph.D. (1)  ·  Chan Kook Park, M.D., Ph.D. (1)  ·  Dae Hwan Kang, M.D., Ph.D. (1)  ·  Dong Ho Lee, M.D., Ph.D. (1)  ·  Dong Ho Lee, M.D.,Ph.D. (1)  ·  Enno Jacobs, MD, PhD (1)  ·  Eun Kwang Choi, M.D., Ph.D. (1)  ·  Geun Am Song, M.D., Ph.D. (1)  ·  Gi Nam Sim, M.D., Ph.D. (1)  ·  Hak Yang Kim, M.D., Ph.D. (1)  ·  Hwoon Yong Jung, M.D., Ph.D. (1)  ·  Hyen Soo Kim, M.D., Ph.D. (1)

Results publications

PMID 27211503, PMID 28960033, PMID 36789577